pocketful logo light
pocketful logo light
Piramal Pharma Ltd logo

Piramal Pharma Ltd

NSE: PPLPHARMA BSE: 543635

₹195.61

(0.56%)

Sat, 08 Aug 2026, 05:11 pm

mtf coin illustrationMTF 5x

Piramal Pharma Share Price Live Chart

1 Day

(0.56%)

No Result Found

Summary

  • Market Cap (in Cr)

    22916.24

  • Net Profit (in Cr)

    91.13

  • P/B

    3.66

  • Sector P/E

    33.76

  • P/E

    325.36

  • EV/EBITDA

    20.63

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    17.01

  • ROCE (Industry)

    16.41

  • RONW (Industry)

    14.52

  • ROE

    1.14

  • ROCE

    6.43

  • Debt/Equity

    0.60

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    61.42

  • Interest Cover

    1.98

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters34.8634.8634.8634.8634.95
FII30.1829.6630.2730.8631.49
DII15.6115.6914.8914.2614.78
Public19.3519.8019.9820.0218.78
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

76.86

MACD

9.27

50 DMA

176.21

200 DMA

170.60

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic260.29224.14209.88187.99173.73151.84115.69
Fibonacci224.14210.33201.80187.99174.18165.65151.84
Camarilla205.55202.24198.92187.99192.30188.98185.67

Pivots Level: Classic

R3

+72.30

260.29

R2

+36.15

224.14

R1

+21.88

209.88

187.99
187.99
Pivot Point
LTP: 209.55

S1

-14.27

173.73

S2

-36.15

151.84

S3

-72.30

115.69

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    199.90

  • 20-EMA

    192.00

  • 30-EMA

    186.95

  • 50-EMA

    180.70

  • 100-EMA

    174.24

  • 200-EMA

    175.13

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 Apr 2026board-meetingsAccounts, Quarterly Results
28 Jan 2026board-meetingsQuarterly Results
05 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
16 Jun 2025dividendFinal Dividend - Rs. - 0.1416 Jul 2025
13 Jun 2025agm
14 May 2025dividend₹0.14 Dividend /Share16 Jul 2025
12 Jun 2024dividendFinal Dividend - Rs. - 0.1112 Jul 2024
11 Jun 2024agm
10 May 2024dividend₹0.11 Dividend /Share12 Jul 2024
27 Jul 2023rights5:46 Rights Issue of Equity Shares02 Aug 2023

Read More

Peer Comparison

Piramal Pharma Ltd logo

Piramal Pharma Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Piramal Pharma Ltd About

Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (“APIs”), Finished dosage forms (“FDFs”), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG“) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and Piramal Consumer Healthcare (“PCH“) business, selling well-known OTC brands.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2020

Headquarters

CEO

Nandini Piramal

Employees

Contact

Website icon

Website

http://www.piramalpharma.com

Email icon

Email

corporate.secretarial@piramal.com

Phone icon

Phone

Location icon

Location

Ananta Bldg Piramal Corporate, Park LBS Marg Kurla west, Mumbai, Maharashtra, 400070

Read More

Piramal Pharma Ltd Company History

YearHistory
2020
  • The company was incorporated on March 4, 2020 at Mumbai as a public limited company.
  • The company acquired the pharmaceutical business from PEL.
  • The company received a 20% Strategic Growth Investment by Carlyle.
  • The company increased its stake to 100% in CCPL.
  • Piramal Pharma and Navin Fluorine mutually agreed on Piramal increasing its stake to 100% in Convergence Chemicals.
  • Piramal Pharma Solutions collaborated with Epirium Bio on an exclusive integrated development and manufacturing program for orphan drugs.
  • Piramal Pharma Solutions announced an integrated development program with Bolt Biotherapeutics for immune-stimulating antibody conjugates and sterile fill-finish.
  • Piramal Critical Care announced a strategic partnership with US-based pharmaceutical outsourcing facility Medivant Healthcare.
2021
  • The company acquired HPPL.
  • Piramal Pharma Solutions announced the winner of its Inaugural Award for Excellence in Patient Centricity.
  • Piramal Pharma Solutions entered into a Master Services Agreement with Plus Therapeutics, Inc.
  • Piramal Pharma Limited's Consumer Products Division launched 'i-feel'.
2022
  • The company acquired a minority stake in Yapan Bio Private Limited.
  • The Composite Scheme of Arrangement was sanctioned by the NCLT on August 12, 2022.
  • Piramal Pharma Solutions announced the winner of its September 2022 Award for Excellence in Patient Centricity.
  • Piramal Pharma Solutions launched ADCelerate, a rapid, integrated approach to taking ADCs to IND.
  • Piramal Pharma Solutions held the grand opening ceremony for its new API plant at Aurora, Canada manufacturing site.
  • Piramal Pharma Solutions' new API plant in Canada went online and initial production runs were successfully completed.
2023
  • The company issued rights shares of Rs. 10 in the ratio of 5:46 at a premium of Rs. 71 per share.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkBuy6856958219.720 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell6856958219.8820 Feb 2025
EAST BRIDGE CAPITAL MASTER FUND LIMITEDblockSell33643099102.831 Oct 2023
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDbulkBuy33643099102.831 Oct 2023
EAST BRIDGE CAPITAL MASTER FUND I LIMITEDblockBuy33643099102.831 Oct 2023
EAST BRIDGE CAPITAL MASTER FUND LIMITEDbulkSell33643099102.831 Oct 2023
CAISSE DE DEPOT ET PLACEMENT DU QUEBECbulkSell1057046694.4816 Jun 2023
THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDbulkBuy620291294.7116 Jun 2023
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell4050700166.9503 Nov 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy4050700166.9503 Nov 2022

Read More

Piramal Pharma Ltd News

Piramal Pharma AGM: Key Resolutions Passed

Piramal Pharma Limited shareholders approved the re-appointment of key directors and authorized non-convertible debenture issuance at its 6th AGM held on July 30, 2026.

30 Jul 2026

companies

Piramal Pharma Q1FY27 Conference Call Recording Now Available

Piramal Pharma Limited has released the audio recording of its Q1FY27 unaudited financial results conference call held on July 30, 2026. The recording is accessible on the company website.

30 Jul 2026

companies

Piramal Pharma targets 25% EBITDA margin by FY30

Piramal Pharma reiterates its target of achieving 25% EBITDA margin across all businesses by FY30, as highlighted in its latest concall update.

30 Jul 2026

companies

Piramal Pharma FY27 CAPEX Guidance: $120M–$135M

Piramal Pharma maintains its FY27 capital expenditure guidance in the range of $120M to $135M, as disclosed during its latest concall update.

30 Jul 2026

companies

Piramal Pharma: EBITDA Margin to Expand on Overseas Growth

Piramal Pharma expects EBITDA margin expansion driven by growth in its overseas business, according to the company's latest concall update.

30 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Piramal Pharma Ltd?

    As of 08/08/2026 at 10:41 PM, Piramal Pharma Ltd shares are trading at ₹195.61.

  • 2.What is the market cap. of Piramal Pharma Ltd?

    As of 08/08/2026, the market capitalization of Piramal Pharma Ltd is ₹26,107.74 crore.

  • 3.When was Piramal Pharma Ltd founded?

    Piramal Pharma Ltd was founded in 2020.

  • 4.How can I buy shares of Piramal Pharma Ltd?

    You can buy shares of Piramal Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 5.What is the shareholding pattern of Piramal Pharma Ltd?

    As of March,2026, promoters hold 34.86% in Piramal Pharma Ltd, while FIIs, DIIs and public shareholders hold 30.18%, 15.61% and 19.35%, respectively. The government holds 0.00%.

  • 6.Does Piramal Pharma Ltd pay dividends?

    Yes, Piramal Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.14 per share.

  • 7.What is the dividend yield of Piramal Pharma Ltd?

    As of 08 August, 2026, the dividend yield of Piramal Pharma Ltd stands at 0.07%.

  • 8.What are the latest financial results of Piramal Pharma Ltd?

    For January,2024, Piramal Pharma Ltd reported revenue of ₹9,146.00 crore and a net profit of ₹91.13 crore.

  • 9.What is the Stock symbol of Piramal Pharma Ltd?

    PPLPHARMA is the stock symbol of Piramal Pharma Ltd.

  • 10.Who is the CEO of Piramal Pharma Ltd?

    The CEO of Piramal Pharma Ltd is Nandini Piramal.

Open Your Free Demat Account

Enter your phone number